Trial Profile
A Phase 2 Study to Assess the Efficacy and Safety of Cannabidiol Oral Solution for the Treatment of Refractory Infantile Spasms
Status:
Active, no longer recruiting
Phase of Trial:
Phase II
Latest Information Update: 26 Sep 2018
Price :
$35
*
At a glance
- Drugs Cannabidiol (Primary)
- Indications Infantile spasms
- Focus Adverse reactions; Therapeutic Use
- Sponsors INSYS Therapeutics, Inc
- 02 Jan 2018 Planned End Date changed from 1 Dec 2017 to 1 Jan 2018.
- 02 Jan 2018 Planned primary completion date changed from 1 Dec 2017 to 1 Jan 2018.
- 30 Nov 2017 Planned End Date changed from 1 Nov 2017 to 1 Dec 2017.